Skip to main content

Table 5 complications in group A and B cases

From: A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death

 

Cardioversion

Pacemaker

Defibrillator

Wall thinning

Heart failure

Heart transplantation

Group A (n)

2 (5.9%)

1 (2.9%)

1 (2.9%)

2 (5.9%)

2 (5.9%)

0

Group B (n)

5 (6.8%)

4 (5.5%)

8 (11.0%)

4 (5.5%)

11 (15.1%)

5 (6.8%)